Mice of lines BI0.D2 (H-2d), abbreviated to D2, and C57BL/6 (H-2b), abbreviated to B6, were obtained from the nursery of the All-Union Oncologic Scientific Center, Academy of Medical Sciences of the USSR. During induction of CTL and MC in vitro, D2 mice were immunized by a single intraperitoneal injection of 2.5.107 EL-4 ascites leukemia cells from B6 mice. To induce STS, 9.107 B6 spleen cells irradiated with y-rays in a dose of 1500 rads (laTCs, 740 rads/min), were injected [4]. CTL also were induced in vitro in a one-way mixed lymphocyte culture (MLC), as described previously [6], using B6 lymphocytes irradiated with x-rays as the stimulating cells. Immune spleen cells obtained 10-12 days after immunization in vivo for 5 days after immunization in vitro were used as primary CTL. To obtain secondary CTL, MC induced in vivo 1-3 months before the experiments were stimulated in MLC by B6 lymphocytes, killed by heating for 1 h at 45~ for 4 days [6]. The resulting CTL were washed, counted, and their cytotoxic index (CI) was determined for action on TC (peritoneal macrophages), labeled with =iCr and cultured for 2 days, using a microversion [7] of the test described previously [8]. To determine activity of STS, D2 mouse spleen cells obtained 3-4 days after immunization (normal D2 spleen cells in the control) were treated with mitomycin C, washed, and added to a one-way D2 anti-B6 MLC, in the ratio of 1:1.5 to the reacting cells [4]. Suppressor activity was calculated by means of the index of inhibition (II) of DNA synthesis.